An unusual presentation of heparin-induced thrombocytopenia in the setting of catheter-directed ablation of atrial fibrillation

Rakhee Vaidya, Rajiv Pruthi, Carrie A Thompson

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Heparin-induced thrombocytopenia type 2 is an immune-mediated phenomenon associated with heparin exposure that has the potential to evolve into life-threatening thrombosis if not recognized and treated early. Lack of immediate availability of a confirmatory assay often leaves the diagnosis to the clinician's discretion. Despite a high negative predictive value, the clinical '4Ts' scoring system carries a small but a real risk of missing the diagnosis, especially with atypical presentations. We describe one such case of rapid-onset, heparin-induced thrombocytopenia with thrombosis that developed in the setting of catheter-directed ablation of atrial fibrillation, several months after a brief exposure to low-molecular-weight heparin. The clinical scenario as well as the risk of progressing to catastrophic complications prompted immediate discontinuation of all heparin products and treatment with a direct thrombin inhibitor, despite a low pretest clinical score.

Original languageEnglish (US)
Pages (from-to)188-190
Number of pages3
JournalBlood Coagulation and Fibrinolysis
Volume25
Issue number2
DOIs
StatePublished - Mar 2014

Fingerprint

Catheter Ablation
Thrombocytopenia
Atrial Fibrillation
Heparin
Thrombosis
Antithrombins
Low Molecular Weight Heparin

Keywords

  • heparin
  • thrombocytopenia
  • thrombosis

ASJC Scopus subject areas

  • Hematology

Cite this

An unusual presentation of heparin-induced thrombocytopenia in the setting of catheter-directed ablation of atrial fibrillation. / Vaidya, Rakhee; Pruthi, Rajiv; Thompson, Carrie A.

In: Blood Coagulation and Fibrinolysis, Vol. 25, No. 2, 03.2014, p. 188-190.

Research output: Contribution to journalArticle

@article{9d8d884883824e8aa13c9f159486aa61,
title = "An unusual presentation of heparin-induced thrombocytopenia in the setting of catheter-directed ablation of atrial fibrillation",
abstract = "Heparin-induced thrombocytopenia type 2 is an immune-mediated phenomenon associated with heparin exposure that has the potential to evolve into life-threatening thrombosis if not recognized and treated early. Lack of immediate availability of a confirmatory assay often leaves the diagnosis to the clinician's discretion. Despite a high negative predictive value, the clinical '4Ts' scoring system carries a small but a real risk of missing the diagnosis, especially with atypical presentations. We describe one such case of rapid-onset, heparin-induced thrombocytopenia with thrombosis that developed in the setting of catheter-directed ablation of atrial fibrillation, several months after a brief exposure to low-molecular-weight heparin. The clinical scenario as well as the risk of progressing to catastrophic complications prompted immediate discontinuation of all heparin products and treatment with a direct thrombin inhibitor, despite a low pretest clinical score.",
keywords = "heparin, thrombocytopenia, thrombosis",
author = "Rakhee Vaidya and Rajiv Pruthi and Thompson, {Carrie A}",
year = "2014",
month = "3",
doi = "10.1097/MBC.0000000000000016",
language = "English (US)",
volume = "25",
pages = "188--190",
journal = "Blood Coagulation and Fibrinolysis",
issn = "0957-5235",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - An unusual presentation of heparin-induced thrombocytopenia in the setting of catheter-directed ablation of atrial fibrillation

AU - Vaidya, Rakhee

AU - Pruthi, Rajiv

AU - Thompson, Carrie A

PY - 2014/3

Y1 - 2014/3

N2 - Heparin-induced thrombocytopenia type 2 is an immune-mediated phenomenon associated with heparin exposure that has the potential to evolve into life-threatening thrombosis if not recognized and treated early. Lack of immediate availability of a confirmatory assay often leaves the diagnosis to the clinician's discretion. Despite a high negative predictive value, the clinical '4Ts' scoring system carries a small but a real risk of missing the diagnosis, especially with atypical presentations. We describe one such case of rapid-onset, heparin-induced thrombocytopenia with thrombosis that developed in the setting of catheter-directed ablation of atrial fibrillation, several months after a brief exposure to low-molecular-weight heparin. The clinical scenario as well as the risk of progressing to catastrophic complications prompted immediate discontinuation of all heparin products and treatment with a direct thrombin inhibitor, despite a low pretest clinical score.

AB - Heparin-induced thrombocytopenia type 2 is an immune-mediated phenomenon associated with heparin exposure that has the potential to evolve into life-threatening thrombosis if not recognized and treated early. Lack of immediate availability of a confirmatory assay often leaves the diagnosis to the clinician's discretion. Despite a high negative predictive value, the clinical '4Ts' scoring system carries a small but a real risk of missing the diagnosis, especially with atypical presentations. We describe one such case of rapid-onset, heparin-induced thrombocytopenia with thrombosis that developed in the setting of catheter-directed ablation of atrial fibrillation, several months after a brief exposure to low-molecular-weight heparin. The clinical scenario as well as the risk of progressing to catastrophic complications prompted immediate discontinuation of all heparin products and treatment with a direct thrombin inhibitor, despite a low pretest clinical score.

KW - heparin

KW - thrombocytopenia

KW - thrombosis

UR - http://www.scopus.com/inward/record.url?scp=84894100676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894100676&partnerID=8YFLogxK

U2 - 10.1097/MBC.0000000000000016

DO - 10.1097/MBC.0000000000000016

M3 - Article

VL - 25

SP - 188

EP - 190

JO - Blood Coagulation and Fibrinolysis

JF - Blood Coagulation and Fibrinolysis

SN - 0957-5235

IS - 2

ER -